CAS RN: 1309760-94-8
Hexakis[μ-(2-amino-1,4-benzenedicarboxylato)][tetra-μ-hydroxyocta-μ-oxooctatitanium], NH2-MIL-125(Ti), CONEKTIC(TM) T125
Product Availability
Choose a grade to view its available package options.
4 package records1 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260428 |
50mg / 250mg / 1g / 5g |
Confirm by inquiry |
Shanghai | 8-10 business days | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250923 |
100mg |
Out of stock |
| | Inquiry |
| Batchno.20250916 |
1g |
Out of stock |
| | Inquiry |
| Batchno.20250625 |
250mg |
Out of stock |
| | Inquiry |
-
Product code:
starshine_CAS1309760-94-8
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
1309760-94-8 / hexakis(2-aminoterephthalate);octakis(oxygen(2-));octakis(titanium(4+));tetrahydroxide
Standard CAS: 1309760-94-8
Multi CAS: No
Basic Information
CAS
1309760-94-8
Multi CAS
No
Molecular Formula
C48H34N6O36Ti8
Molecular Weight
1653.700000
Exact Mass
1653.684947
SMILES
C1=CC(=C(C=C1C(=O)[O-])N)C(=O)[O-].C1=CC(=C(C=C1C(=O)[O-])N)C(=O)[O-].C1=CC(=C(C=C1C(=O)[O-])N)C(=O)[O-].C1=CC(=C(C=C1C(=O)[O-])N)C(=O)[O-].C1=CC(=C(C=C1C(=O)[O-])N)C(=O)[O-].C1=CC(=C(C=C1C(=O)[O-])N)C(=O)[O-].[OH-].[OH-].[OH-].[OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Ti+4].[Ti+4].[Ti+4].[Ti+4].[Ti+4].[Ti+4].[Ti+4]
InChI
InChI=1S/6C8H7NO4.4H2O.8O.8Ti/c6*9-6-3-4(7(10)11)1-2-5(6)8(12)13;;;;;;;;;;;;;;;;;;;;/h6*1-3H,9H2,(H,10,11)(H,12,13);4*1H2;;;;;;;;;;;;;;;;/q;;;;;;;;;;8*-2;8*+4/p-16
InChIKey
JMUQHBVQFASBBK-UHFFFAOYSA-A
Computed Properties
Structural Parameters
Heavy atom count
98
Aromatic heavy atom count
36
Rotatable bonds
12
H-bond acceptors
34
H-bond donors
6
Molar refractivity
250.33
TPSA
985.68
LogP / Solubility
WLOGP
-13.7
MLOGP
-11.88
XLogP3
-13.7
Consensus LogP
-13.09
Log S (ESOL)
-0.94
Class (ESOL)
Very soluble
Log S (Ali)
-3.23
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-0.48
Class (SILICOS-IT)
Very soluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-22.54
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
5.5